LCM Capital Management Inc
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1861752
CHICAGO, IL
Position in RXRX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$55,050
+$18,210 QoQ
Shares Held
15,000
+25.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#225
of 340 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LCM Capital Management Inc holds $1,381,075 across 6 Biotechnology names. RXRX ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,196 | $594,089 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
603 | $375,994 | |
| 3 | INCY |
Incyte Corp
|
2,158 | $244,630 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
15,000 | $85,200 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
15,000 | $55,050 | |
| 6 | GERN |
Geron Corp
|
20,400 | $26,112 |
All Filings in RXRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,050 | 15,000 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $36,840 | 12,000 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $49,080 | 12,000 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $58,560 | 12,000 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $60,720 | 12,000 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $63,480 | 12,000 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||